Variable response to radioactive iodine treatment in poorly differentiated thyroid carcinoma.
作者信息
Underwood Hunter J, Shaha Ashok R, Patel Kepal N
机构信息
Division of Endocrine Surgery, NYU Langone Health, New York, NY, USA.
Head and Neck Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
出版信息
Gland Surg. 2019 Dec;8(6):589-590. doi: 10.21037/gs.2019.10.14.
Abstract
摘要
相似文献
1
Variable response to radioactive iodine treatment in poorly differentiated thyroid carcinoma.
Gland Surg. 2019 Dec;8(6):589-590. doi: 10.21037/gs.2019.10.14.
2
The Treatment of Well-Differentiated Thyroid Carcinoma.
Dtsch Arztebl Int. 2015 Jun 26;112(26):452-8. doi: 10.3238/arztebl.2015.0452.
3
Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
Surgery. 2017 Jan;161(1):127-133. doi: 10.1016/j.surg.2016.05.056. Epub 2016 Nov 14.
4
Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?
World J Surg. 1992 Jul-Aug;16(4):640-5; discussion 645-6. doi: 10.1007/BF02067343.
5
Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
Thyroid. 2018 Jul;28(7):902-912. doi: 10.1089/thy.2017.0136.
6
Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma.
Surgery. 2010 Mar;147(3):424-31. doi: 10.1016/j.surg.2009.10.009.
7
Radioactive Iodine-Refractory Differentiated Thyroid Cancer in the Elderly.
Curr Oncol Rep. 2018 Sep 11;20(10):82. doi: 10.1007/s11912-018-0736-4.
8
A Unique Case of Intranasal Metastasis from Occult Poorly Differentiated Thyroid Carcinoma.
Balkan Med J. 2015 Jul;32(3):316-9. doi: 10.5152/balkanmedj.2015.15533. Epub 2015 Jul 1.
9
Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.
Clin Nucl Med. 2018 Jul;43(7):482-485. doi: 10.1097/RLU.0000000000002078.
10
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Lancet Diabetes Endocrinol. 2019 Jan;7(1):44-51. doi: 10.1016/S2213-8587(18)30306-1. Epub 2018 Nov 27.
引用本文的文献
1
An Unexpected Finding of Poorly Differentiated Thyroid Carcinoma in a Toxic Thyroid Nodule.
JCEM Case Rep. 2023 May 23;1(3):luad052. doi: 10.1210/jcemcr/luad052. eCollection 2023 May.
2
The role of external beam radiation therapy in the management of thyroid carcinomas: A retrospective study in Iran Cancer Institute.
Cancer Rep (Hoboken). 2023 Jan;6(1):e1652. doi: 10.1002/cnr2.1652. Epub 2022 Jun 12.
3
Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation - association or random chance?
Thyroid Res. 2021 Aug 14;14(1):19. doi: 10.1186/s13044-021-00110-4.
4
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC.
Cancers (Basel). 2021 Apr 6;13(7):1728. doi: 10.3390/cancers13071728.
本文引用的文献
1
Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Thyroid. 2019 Oct;29(10):1425-1437. doi: 10.1089/thy.2019.0284. Epub 2019 Aug 16.
2
Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study.
World J Otorhinolaryngol Head Neck Surg. 2018 Aug 11;5(1):34-40. doi: 10.1016/j.wjorl.2018.05.006. eCollection 2019 Mar.
3
p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer.
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):E1600-9. doi: 10.1073/pnas.1404357111. Epub 2014 Apr 7.
4
Poorly differentiated thyroid carcinoma: an incubating entity.
Front Endocrinol (Lausanne). 2012 Jun 21;3:77. doi: 10.3389/fendo.2012.00077. eCollection 2012.
5
Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
Clin Endocrinol (Oxf). 2007 Feb;66(2):224-8. doi: 10.1111/j.1365-2265.2006.02712.x.
6
Poorly differentiated and anaplastic thyroid cancer.
Cancer Control. 2006 Apr;13(2):119-28. doi: 10.1177/107327480601300206.
7
Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
Endocr Pathol. 2004 Winter;15(4):319-27. doi: 10.1385/ep:15:4:319.
Zotero 插件